Matches in Wikidata for { <http://www.wikidata.org/entity/Q64151896> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q64151896 description "clinical trial" @default.
- Q64151896 description "ensayu clínicu" @default.
- Q64151896 description "klinisch onderzoek" @default.
- Q64151896 description "клінічне випробування" @default.
- Q64151896 description "կլինիկական փորձարկում" @default.
- Q64151896 name "Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia" @default.
- Q64151896 type Item @default.
- Q64151896 label "Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia" @default.
- Q64151896 prefLabel "Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia" @default.
- Q64151896 P1050 Q64151896-BFAC40E2-F502-46A2-86A3-CA438C89B64D @default.
- Q64151896 P1132 Q64151896-7F69B02A-9E0F-4E95-9E42-A99DAA717151 @default.
- Q64151896 P1476 Q64151896-703702EC-145C-4504-9884-7A832935668E @default.
- Q64151896 P17 Q64151896-517971E5-8E50-4B0A-91B6-92E191AE8E60 @default.
- Q64151896 P17 Q64151896-B6334876-D2EA-4ED6-A049-1801955D1F93 @default.
- Q64151896 P17 Q64151896-CB092E6A-A916-452B-BED9-936EDFB7288C @default.
- Q64151896 P2899 Q64151896-DBCC8A0B-5176-4207-9DBA-362EE9A7BCDF @default.
- Q64151896 P3098 Q64151896-86E01BD2-4360-4157-8F2C-3507624FED44 @default.
- Q64151896 P31 Q64151896-F37A6003-661D-4E1A-B976-8EDA455383D6 @default.
- Q64151896 P580 Q64151896-5BD0F30C-9ED1-4CB8-B09B-445E7382E1E7 @default.
- Q64151896 P582 Q64151896-2F2E3BA2-9183-4B57-AF77-C2295FB585DE @default.
- Q64151896 P6099 Q64151896-59BA0D4D-36FC-42FF-9279-007D9856ABC0 @default.
- Q64151896 P6099 Q64151896-87C1E070-BE4F-490A-A765-BC9E5E307F92 @default.
- Q64151896 P8363 Q64151896-10553096-A92A-4040-B5E5-ECF9CDE3072D @default.
- Q64151896 P1050 Q29496 @default.
- Q64151896 P1132 "+265" @default.
- Q64151896 P1476 "A Phase 1/2 Open-Label, Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia" @default.
- Q64151896 P17 Q183 @default.
- Q64151896 P17 Q30 @default.
- Q64151896 P17 Q38 @default.
- Q64151896 P2899 "+18" @default.
- Q64151896 P3098 "NCT02014558" @default.
- Q64151896 P31 Q30612 @default.
- Q64151896 P580 "2013-10-09T00:00:00Z" @default.
- Q64151896 P582 "2017-08-04T00:00:00Z" @default.
- Q64151896 P6099 Q42824440 @default.
- Q64151896 P6099 Q5452194 @default.
- Q64151896 P8363 Q78089383 @default.